Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 8,178 | 7,756 | 7,684 | 7,784 | 7,562 |
| Operating Income | -8,178 | -7,756 | -7,684 | -7,784 | -7,562 |
| Other Income | 230 | 9,583 | 2,521 | -25 | 35,423 |
| Pre-tax Income | -7,948 | 1,827 | -5,163 | -7,809 | 27,861 |
| Net Income Continuous | -7,948 | 1,827 | -5,163 | -7,809 | 27,861 |
| Net Income Discontinuous | N/A | 946 | 521 | 165 | 149 |
| Net Income | $-7,948 | $2,773 | $-4,642 | $-7,644 | $28,010 |
| EPS Basic Total Ops | -53.95 | 17.38 | -42.29 | -66.08 | 245.82 |
| EPS Basic Continuous Ops | -53.95 | 11.45 | -46.46 | -67.40 | 244.49 |
| EPS Basic Discontinuous Ops | N/A | 5.93 | 4.43 | 1.43 | 1.31 |
| EPS Diluted Total Ops | -53.95 | 17.38 | -42.29 | -66.08 | 245.82 |
| EPS Diluted Continuous Ops | -53.95 | 11.45 | -46.50 | -67.40 | 244.49 |
| EPS Diluted Discontinuous Ops | N/A | 5.93 | 4.42 | 1.43 | 1.31 |
| EPS Diluted Before Non-Recurring Items | -54.19 | 11.45 | N/A | N/A | N/A |
| EBITDA(a) | $-8,028 | $-7,578 | $-7,523 | $-7,562 | $-7,286 |